| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |